High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

@article{Stupp2014HighgradeGE,
  title={High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.},
  author={Roger Stupp and Michael Brada and Martin J. van den Bent and J C Tonn and George Pentheroudakis},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2014},
  volume={25 Suppl 3},
  pages={iii93-101}
}
R. Stupp1, M. Brada2, M. J. van den Bent3, J.-C. Tonn4 & G. Pentheroudakis5 on behalf of the ESMO Guidelines Working Group* Department of Oncology and Cancer Centre, University Hospital Zurich, Zurich, Switzerland; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Clatterbridge Cancer Centre, Wirral, UK; Department of Neuro-Oncology, Erasmus MC Cancer Center, Rotterdam, Netherlands; Department of Neurosurgery, Ludwig-Maximilians-University, Munich, Germany… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 13 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 79 extracted citations

Diagnostic Performance of Arterial Spin Labeling for Grading Nonenhancing Astrocytic Tumors

Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine • 2018

References

Publications referenced by this paper.
Showing 1-10 of 74 references

Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2013
View 14 Excerpts
Highly Influenced

IDH1 and IDH2 mutations in gliomas.

The New England journal of medicine • 2009
View 4 Excerpts
Highly Influenced

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2009
View 4 Excerpts
Highly Influenced

Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2013
View 2 Excerpts

Similar Papers

Loading similar papers…